specific antigen

Related by string. * specifi c . specifics . Specifics . Specific : Specific Questions relating . specific membrane antigen . Specific Plan / antigens . Antigen . Antigens : Prostate Specific Antigen PSA . antigen presenting cells . antigen sparing * prostate specific antigen . Prostate Specific Antigen . Prostate specific antigen . tumor specific antigen . specific antigen PSA *

Related by context. All words. (Click for frequent words.) 77 PSA prostate 73 prostate specific 73 prostate specific antigen 72 Prostate Specific Antigen PSA 68 Prostate Specific Antigen 68 antigen PSA 67 specific antigen PSA 66 thyroid stimulating hormone 65 mesothelin 65 thyroglobulin 65 serum PSA 64 serum prostate 63 B7 H3 63 clusterin 62 Prostate specific antigen 62 urine cytology 61 HER2 expression 61 KRAS mutation 61 cystatin C 61 Ki# 61 PCa 61 cTnT 60 adenoma 60 Lp PLA2 60 NGAL 60 prostate cancer CaP 60 digital rectal examination 60 BRAF mutation 60 troponin T 60 pCR 60 hydroxyvitamin D levels 60 HER2 protein 59 precursor lesions 59 BRCA mutations 59 HER2 receptors 59 serum IgE 59 antibody titer 59 eosinophil count 59 antigen PSA levels 59 IgA 59 FDG-PET/CT 59 immunochemical 59 chlamydial infection 59 ASCUS 59 abnormal cytology 59 troponins 59 carcinoembryonic antigen 59 NMP# 59 fecal occult blood 59 autoantibodies 59 MSMB 59 PSA velocity 59 ERCC1 59 prostate tumor 59 thyroid stimulating hormone TSH 59 elevated CRP 59 Clusterin 59 #.#ng/ml 59 carcinoembryonic antigen CEA 59 SPINK1 59 Her2/neu 59 prostate biopsy 58 atypia 58 advanced neoplasia 58 HbF 58 HER2 receptor 58 C reactive protein 58 WT1 58 HAAH 58 estrogen receptor ER 58 follicle stimulating hormone FSH 58 C Reactive Protein 58 lymph node metastases 58 reticulocytes 58 ELISpot 58 fine needle aspiration 58 epithelial tumors 58 BRAF mutations 58 grade cervical intraepithelial 58 BRCA mutation 58 benign polyps 58 RBP4 58 PCA3 58 atypical hyperplasia 58 IgG antibodies 58 breast carcinomas 58 HER2 58 HER2 gene 58 PSA nadir 58 oncoprotein 58 endoglin 58 HER-2/neu 58 micrometastases 58 prostate tissue 58 guaiac 58 EpCAM 58 MAGE A3 58 albuminuria 58 PSA screening 58 cTnT levels 58 test FOBT 58 CIN2 + 57 gene amplification 57 vimentin 57 Her2 57 axillary lymph nodes 57 invasive carcinoma 57 cardiac troponin T 57 nestin 57 precancer 57 HER2 amplification 57 hsCRP 57 cortisol concentrations 57 thyroxine 57 PGDH 57 estrogen receptor 57 lactate dehydrogenase LDH 57 TSP1 57 BRCA2 mutation carriers 57 serum ferritin 57 sarcosine 57 colorectal neoplasms 57 antigen 57 HPV# 57 TNFa 57 KRAS mutations 57 urine albumin 57 GSTP1 57 myeloperoxidase 57 faecal occult blood 57 CIN3 + 57 methylated DNA 57 FDG PET 57 immunohistochemical 57 RECAF 57 adenomatous polyps 56 ovarian hormones 56 troponin 56 PSADT 56 elevated creatinine 56 lymph node metastasis 56 sentinel lymph node biopsy 56 skin sterol 56 renal cell carcinomas 56 ADPKD 56 enterolactone 56 prognostic indicator 56 atypical ductal hyperplasia 56 cytokeratin 56 digital rectal exams 56 leukocytosis 56 NMP# protein 56 IGFBP 56 pDCs 56 TIMP 56 GPNMB 56 MUC1 protein 56 serum antibodies 56 transferrin saturation 56 HER2 overexpression 56 exhaled nitric oxide 56 follicle stimulating hormone 56 HGPIN 56 interferon gamma 56 Elevated PSA 56 PlGF 56 p#INK#a 56 Mesothelin 56 ptau 56 biopsies 56 pelvic ultrasound 56 CIN3 56 serum testosterone 56 androgen receptors 56 risk HPV genotypes 56 homocysteine concentrations 56 cervical lesions 56 peripheral blood mononuclear 56 undergo prostate biopsy 56 tHcy 56 #F FDG 56 peptide antigens 56 BRCA1 mutations 56 RASSF1A 56 HER2/neu 56 prostate cancers 56 MUC1 56 SHBG 56 ovarian carcinoma 56 VEGF expression 56 S#A# [002] 56 colorectal neoplasia 56 intact parathyroid hormone 56 EUS FNA 56 malignant prostate 56 immunochemical fecal occult 55 Stat5 55 RANTES 55 colonic polyps 55 androgen receptor AR 55 transthyretin 55 IGF IR 55 pmol L 55 prostate adenocarcinoma 55 mRNA expression 55 lobular carcinoma 55 malignant transformation 55 Lp PLA 2 55 advanced adenomas 55 methylation markers 55 IgE antibodies 55 pleural fluid 55 neoplasia PIN 55 rheumatoid factor 55 PCA3 gene 55 serologic 55 serum calcium 55 urate 55 serum concentrations 55 F FDG PET 55 CT colonography 55 coronary artery calcium 55 neoplastic 55 metastatic prostate 55 CD# protein 55 estrogen metabolites 55 iNOS 55 D dimer 55 biochemical recurrence 55 EGFR protein 55 basal cell nevus syndrome 55 metastatic prostate cancer 55 colorectal cancer CRC 55 microalbuminuria 55 asymptomatic carotid stenosis 55 grade gliomas 55 sFlt 1 55 cardiac troponin 55 platelet reactivity 55 Lymph node 55 micrometastasis 55 microsatellite instability 55 serous ovarian cancer 55 Cervista HPV HR 55 immunohistochemical analysis 55 pituitary adenomas 55 serum albumin 55 creatinine levels 55 invasive lobular carcinoma 55 ApoB 55 NSCLC tumors 55 granulocytes 55 serum thyroglobulin 55 thyrotropin 55 F2 isoprostanes 55 neoadjuvant therapy 55 chemosensitivity 55 folate intake 55 HBsAg 55 creatinine 55 PAP smear 55 EphB4 55 serum creatinine levels 55 PKCi 55 antigens 55 malignant lesions 55 FGFR1 55 urine NGAL 55 protein albumin 55 HIV RNA 55 sentinel lymph node 55 hs CRP 55 thyroid nodules 55 abdominal adiposity 55 mediated immunity 55 neoplasia 55 osteopontin 55 situ LCIS 55 histopathologic examination 55 colorectal carcinoma 55 serum calcium levels 55 molecular biomarkers 55 digital rectal exam 55 IGFBP 3 55 estrogen receptor progesterone receptor 55 EGFR mutations 55 HER-2/neu protein 55 Estradiol 54 pancreatic lung 54 endometrial cancers 54 selenium supplementation 54 urothelial carcinoma 54 subclinical hyperthyroidism 54 glycosylated hemoglobin 54 biomarker 54 advanced adenoma 54 mammaglobin 54 conventional coronary angiography 54 ELISPOT 54 resistin 54 elevated LDL cholesterol 54 antibody titers 54 immunohistochemical staining 54 HbA1C 54 testicular cancers 54 adiponectin levels 54 ImmuKnow 54 GISTs 54 somatic mutations 54 abnormal mammogram 54 TLR3 54 CaP 54 ductal cancer 54 elevated homocysteine 54 prostate tumors 54 clinically insignificant 54 chest radiographs 54 β amyloid 54 lipoprotein 54 androgens 54 procalcitonin 54 sentinel node biopsy 54 colonoscopy flexible sigmoidoscopy 54 anti androgen 54 node metastases 54 PCA3 scores 54 breast tumors 54 IGF 1R 54 abnormal Pap 54 glomerular filtration rate 54 methylation 54 colon tumors 54 mammographic density 54 Inhibin B 54 chromosomal aberrations 54 histological subtype 54 miRNA expression 54 nonmelanoma skin cancers 54 mammographically 54 tumors 54 cTnI 54 metastatic lesions 54 seminoma 54 lobular carcinomas 54 ovarian tumors 54 catheter angiography 54 nanomolar 54 DHEAS 54 Coronary artery calcium 54 Rh factor 54 EGFRvIII 54 HLA B# 54 procaspase 3 54 K ras mutations 54 alkaline phosphatase 54 sentinel nodes 54 rs# [002] 54 MDM2 54 malignant nodules 54 aT cell 54 cervical intraepithelial neoplasia 54 eGFR 54 CLL cells 54 IgM 54 AGTR1 54 soluble CD# ligand 54 gastrointestinal stromal tumors GISTs 54 transrectal ultrasound guided 54 cervical carcinoma 54 Septin9 54 endoxifen 54 endometrial hyperplasia 54 nuchal translucency 54 trophoblast cells 54 thyroxine T4 54 pre cancerous growths 54 FGFR3 54 Adenomas 54 estrogen progesterone 54 colorectal carcinomas 54 Pap smear 54 CPE delta N 54 Western blot 54 BRCA deficient 54 MGd 54 IFN gamma 54 transvaginal ultrasound 54 cytological 54 mucinous 54 tPSA 54 serum testosterone levels 54 EGFr 54 microalbumin 54 tumor antigen 54 alanine aminotransferase ALT 54 leukocyte 54 mammary cancers 54 imatinib Gleevec 54 adenocarcinomas 54 glycated hemoglobin 54 prostate abnormalities 54 EGFR mutation 54 FISH fluorescence 54 tumor hypoxia 54 CD4 + CD# 53 thyroid peroxidase 53 core needle biopsies 53 basal cells 53 c reactive protein 53 Hurthle cell 53 HER2 positive cancers 53 fecal immunochemical test 53 B7 H4 53 aminotransferases 53 activated lymphocytes 53 N telopeptide 53 microRNA expression 53 poorer prognosis 53 prostate carcinoma 53 hydroxyvitamin D concentrations 53 peptide BNP 53 surgical biopsy 53 prostate ovarian 53 Recurrence Score 53 ferritin 53 alpha defensins 53 breast cancer metastasis 53 hCG beta 53 fetuin 53 helical CT 53 tumor cells 53 epithelial ovarian cancer 53 homocysteine levels 53 cerebrospinal fluid CSF 53 Septin 9 53 albumin protein 53 intestinal polyps 53 lymphocytes 53 premalignant lesions 53 glomerular filtration 53 pre cancerous polyps 53 neoplastic cells 53 bladder cancers 53 ^ sup #m 53 micronuclei 53 Neisseria gonorrhoeae 53 hemoglobin A1C 53 tryptase 53 intestinal biopsy 53 breast endometrial 53 maternal serum 53 tumor xenografts 53 colorectal cancers 53 hydroxy vitamin D 53 hormone deprivation 53 operable breast cancer 53 NQO1 53 ductal 53 USPSTF recommends 53 GBM tumors 53 Metastases 53 proto oncogene 53 distant metastasis 53 immunoglobulin G 53 hematopoietic cells 53 ZNF# 53 prostatic fluid 53 leiomyomas 53 prognostic marker 53 adiponectin 53 cardiac biomarkers 53 gamma interferon 53 tumor biopsies 53 colorectal tumors 53 NKG2D 53 BLyS 53 invasive coronary angiography 53 male hormones androgens 53 GRP# 53 IgG antibody 53 chromosomal abnormalities 53 antibodies 53 ductal breast cancer 53 TGFBR1 * 6A 53 Gram stain 53 gastric carcinoma 53 acid phosphatase PAP 53 sentinel lymph nodes 53 periodontal bacteria 53 GnRH agonists 53 Androgen deprivation therapy 53 Epidemiologic studies 53 BCL#A 53 QuantiFERON 53 immunohistochemistry IHC 53 Immunohistochemistry 53 H pylori 53 ovarian malignancy 53 hTERT 53 pre cancerous 53 radioiodine therapy 53 squamous intraepithelial lesions 53 pleural mesothelioma 53 microvessel density 53 sitosterol 53 Metastatic 53 sentinel node 53 prostate cancer PCa 53 histologically 53 ADAM# 53 homodimers 53 luteinising hormone 53 pre cancerous lesions 53 RQ PCR 53 Fecal occult blood 53 chlamydial 53 hormone receptor negative 53 nonalcoholic steatohepatitis NASH 53 IGFBP2 53 hemoglobin hematocrit 53 IL 1beta 53 sortilin 53 urate levels 53 endometrial tumors 53 radiotracer 53 contralateral breast 53 TIMP 1 53 abnormal Pap test 53 SUVmax 53 serum urate levels 53 abnormal cervical 53 anti JCV antibodies 53 beta1 integrin 53 precancerous condition 53 serum vitamin D 53 antibody responses 53 prostate 53 malondialdehyde 53 androgen receptor 53 colorectal gastric 53 NAbs 53 DEXA scan 53 inflammatory markers 53 esophageal adenocarcinoma 53 trastuzumab Herceptin 53 albumin excretion 53 EphA2 53 μg dL 53 ApoA1 53 H. pylori 53 YKL 53 Doppler sonography 53 peritoneal cancer 53 SHBG levels 53 BRCA2 mutations 53 cisplatin resistant 53 melanoma tumors 53 metastatic lymph nodes 53 thickness IMT 53 HER2 ErbB2 53 gene polymorphisms 53 plasma folate 53 biochemical relapse 53 hormonal therapies 53 biochemical marker 53 Pap test 53 B7 H1 53 serum cortisol 53 MGMT gene 53 aneuploidy 53 breast carcinoma 53 NPM1 53 obstructive coronary artery 53 prion infection 53 colorectal adenoma 53 endometrial carcinoma 53 GSTT1 53 colorectal cancer 53 ovarian pancreatic 53 caveolin 1 53 human leukocyte antigens 53 pancreatic adenocarcinoma 53 ErbB2 positive 53 LRP5 53 oxysterols 53 metastatic tumors 53 BRCA2 carriers 53 precancerous cervical lesions 53 nodal metastasis 53 PTEN gene 53 immunohistochemistry 53 carotid ultrasound 53 EBRT 53 genetic polymorphisms 53 ADAMTS# 53 immunoreactivity 53 premalignant lesion 52 dose ionizing radiation 52 PIK3CA 52 IgA deficiency 52 testosterone supplementation 52 Sjögren syndrome 52 transgene expression 52 Epstein Barr virus EBV 52 luteinizing hormone 52 hamartomas 52 lobular involution 52 biomarkers 52 SOX9 52 fluorodeoxyglucose 52 androgen independent 52 epithelial cancers 52 #HC 52 hydroxyvitamin D 52 mutant p# 52 positron emission tomography scan 52 genomic alterations 52 adjuvant radiotherapy 52 squamous cell 52 lactate dehydrogenase 52 TAp# 52 PSMA protein 52 natriuretic peptides 52 estrogen receptor negative 52 interstitial fluid 52 autoantibody 52 8 OHdG 52 latent tuberculosis infection 52 homocysteine 52 E. faecalis 52 HER2 positive tumors 52 costimulatory 52 EGFR inhibitors 52 transfected cells 52 progranulin 52 conventional Pap smear 52 serum CRP 52 low expressors 52 EGF receptors 52 fasting glucose levels 52 galectin 3 52 EGFR 52 leukocyte count 52 serum uric acid 52 hematopoietic cancers 52 Leydig cell 52 Immunohistochemical analysis 52 CMV infection 52 RKIP 52 palladin 52 IgG 52 lymph node biopsies 52 selenium intake 52 inhibin B 52 telomerase activation 52 endometrial 52 dietary folate 52 serum antibody 52 grade squamous intraepithelial 52 axillary dissection 52 OGG1 52 alkaline phosphatase ALP 52 thioredoxin 52 osteoblast 52 gastric adenocarcinoma 52 tNOX 52 screening mammography 52 leukocytes 52 hypermethylation 52 pelvic lymphadenectomy 52 sestamibi 52 TRUS 52 EZH2 52 ABCB1 52 benign moles 52 axillary lymph node 52 squamous 52 breast tissue 52 Doppler ultrasound 52 flexible sigmoidoscopy 52 androgen deficiency 52 alkylating agents 52 Cyclin E 52 RBC folate 52 erythrocyte sedimentation rate 52 premalignant 52 plasma lipid 52 telomere lengths 52 KRAS oncogene 52 subclinical hypothyroidism 52 coronary calcium 52 hENT1 52 VZV 52 perfusion imaging 52 elevated LDH 52 prognostic significance 52 SLNB 52 serum TSH 52 HCV replicon 52 virulence genes 52 PCR assay 52 benign breast 52 soluble endoglin 52 promoter methylation 52 precancers 52 homodimer 52 cyclin D1 52 polyp detection 52 IgA antibodies 52 IgE 52 MammaPrint R 52 analyte 52 benign lesions 52 p# mutations 52 familial ALS 52 metastatic melanomas 52 detecting colorectal cancer 52 mtDNA mutations 52 BRAF gene 52 sarcomatoid 52 hemoglobin Hb 52 serological tests 52 ductal lobular 52 renal tumors 52 mesotheliomas 52 microcalcifications 52 azacytidine 52 IL#B 52 axillary node dissection 52 adjuvant therapy 52 orchiectomy 52 Rectal cancer 52 BRCA2 52 oncogenic transformation 52 TGF ß1 52 fecal occult 52 Endometrial 52 biochemical markers 52 OGTT 52 histone modifications 52 ovarian endometrial 52 prostate biopsies 52 serum selenium 52 EBV infection 52 activating mutations 52 prognostic factor 52 parathyroid 52 cytologic 52 cyclic AMP cAMP 52 preoperative chemotherapy 52 monocyte chemoattractant protein 52 inflammatory biomarkers 52 IgE antibody 52 ELISPOT assay 52 sCJD 52 HER2 neu 52 miRNA molecules 52 epithelial cells 52 alpha fetoprotein AFP 52 52 FOXP3 52 leukemic cell 52 BRCA1 mutation 52 iPTH 52 androgens male 52 deCODE BreastCancer 52 latent TB infection 52 malignant ovarian 52 sDNA 52 BRAF V#E mutation 52 AhR 52 conventional cytology 52 abnormal growths 52 Kupffer cells 52 CLA supplementation 52 pulmonary metastases 52 RIP1 52 hypogonadal 52 metastatic colorectal 52 genes BRCA1 52 tissue transglutaminase 52 cell adhesion molecule 52 lobular breast cancer 52 mesothelial cells 52 Wwox 52 HPV 52 TSLP 52 epithelial tissues 52 urine dipstick 52 colon rectal 52 BRCA1 52 neuroblastoma tumors 52 leukaemias 52 endogenous EPO 52 thyrotropin levels 52 lymphocytosis 52 Neutrophil 52 adjuvant radiation 52 deCODE ProstateCancer TM 52 MIF protein 52 excisional biopsy 52 mediastinoscopy 52 bladder tumors 52 PECAM 1 52 glycosylated hemoglobin HbA1c 52 Hashimoto thyroiditis 52 ErbB2 52 malignant pleural mesothelioma 52 fibrocystic changes 52 cervical cytology 52 MGUS 52 prostate cancer 52 breast lesions 52 KRAS variant 52 circulating EPCs 52 hepatocellular carcinomas 52 intestinal metaplasia 52 Biopsies 52 Corus CAD 52 pathogenic mutations 52 lymphoid tissue 52 adenomas 52 #F FDG PET 52 Homocysteine levels 52 P. gingivalis 51 HER2 positive 51 KRAS status 51 Squamous 51 serum phosphate 51 seminomas 51 clinico pathological 51 mutated BRAF gene 51 NT proBNP 51 LHRH agonists 51 cranial irradiation 51 colorectal pancreatic 51 androgen deprivation 51 FeNO 51 D Dimer 51 prognostic markers 51 AST ALT 51 deCODE BreastCancer TM 51 microalbumin test 51 Cholangiocarcinoma 51 cancers 51 APOE e4 51 human leukocyte antigen 51 biopsied tissue 51 CD8 cells 51 tumor specific antigen 51 serum cholesterol 51 amino acid homocysteine 51 hereditary breast cancer 51 Homocysteine 51 pre malignant lesions 51 PTEN mutations 51 human chorionic gonadotropin hCG 51 hormone receptor positive 51 androgen therapy 51 cholangiocarcinoma 51 c MYC 51 adenomatous 51 Her-2/neu 51 bowel polyps 51 NF kappaB activation 51 mutated K ras 51 oxidized lipids 51 sPLA2 51 haematopoietic 51 HCV antibody 51 immunostaining 51 TGF alpha 51 cerebral microbleeds 51 PSA Prostate Specific 51 HER2 positive metastatic breast 51 leukemic cells 51 hypermethylated 51 carotid plaque 51 skeletal metastases 51 AAV2 51 papillary 51 Getzenberg 51 benign growths 51 P selectin 51 BSGI MBI 51 TNF α 51 Skin sterol 51 seronegative 51 APOE gene 51 CCR7 51 bone density measurements 51 ERBB2 51 axillary nodes 51 paricalcitol 51 glycosylated 51 alpha fetoprotein 51 genetic biomarkers 51 Adenocarcinoma 51 hormone receptor status 51 chitinase 51 lymphatic tissue 51 cervical smears 51 osteosarcomas 51 unresectable tumors 51 serotonin synthesis 51 PrPSc 51 serum potassium 51 apolipoproteins 51 endometrioid 51 PLCO 51 p# mutation 51 carotid stenosis 51 nitrotyrosine 51 metastatic disease 51 HC2 test 51 thyroid carcinoma 51 neutralizing antibodies 51 IFNg 51 flavopiridol 51 endometrial ovarian 51 specific IgE 51 LQTS 51 gonococcal infection 51 interleukin IL -# 51 stromal cells 51 carcinomas 51 proinflammatory cytokines 51 coronary artery calcification 51 SGPT 51 Epidermal Growth Factor Receptor 51 plasminogen 51 mammary cells 51 CYP#D# 51 PET CT scans 51 HLA DQ 51 endogenous estrogen 51 ductal lavage 51 taxane therapy 51 p#NTR 51 EphB2 51 GSTM1 51 nodal metastases 51 malignancy 51 paraprotein 51 VKORC1 51 Zolinza 51 varicoceles 51 intima media thickness 51 invasive lobular 51 mitochondrial toxicity 51 serum IGF 51 proteinuria 51 MMP2 51 thickness CIMT 51 titer 51 albumin excretion rate 51 CYP#A# [002] 51 triiodothyronine 51 Flexi Scope 51 asymptomatic 51 TGF β 51 lipoprotein associated phospholipase 51 GBV C 51 Elevated serum 51 HLA antigens 51 MTHFR 51 Sertoli cells 51 androgen deprivation therapy 51 colorectal tumor 51 neoadjuvant 51 CD#b 51 Papanicolaou Pap 51 fasting glucose 51 annexin V 51 M. pneumoniae 51 anti HBs 51 castrate resistant 51 FLT3 51 MnSOD 51 oncoproteins 51 cancerous polyps 51 genistein 51 endostatin 51 ovarian lung 51 anti Mullerian hormone 51 chronic prostatitis 51 suppressor gene 51 situ CIS 51 carcinoid tumor 51 histological subtypes 51 precancerous tumors 51 isoprostane 51 UCP2 51 platelet aggregation 51 viral antigens 51 MDSCs 51 duplex ultrasonography 51 estrogen receptor alpha 51 biomarker assay

Back to home page